Blend Labs (BLND) PT Lowered to $5.25 at Goldman Sachs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BLND Hot Sheet
Price: $1.28 --0%
Rating Summary:
5 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 19 | New: 2
Rating Summary:
5 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 19 | New: 2
Join SI Premium – FREE
Goldman Sachs analyst Michael Ng lowered the price target on Blend Labs (NYSE: BLND) to $5.25 (from $6.00) while maintaining a Buy rating.
You May Also Be Interested In
- Morgan Stanley Downgrades HubSpot Inc (HUBS) to Equalweight
- ADMA Biologics (ADMA) PT Raised to $18 at Mizuho
- MercadoLibre (MELI) PT Lowered to $2,000 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
